Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
Clinical trial NCT01861106 · RECRUITING
Trial details
- NCT number
- NCT01861106
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-24
- Primary completion
- 2027-12-31
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.